Osteoprotegerin Deficiency (Juvenile Paget's Disease): Responses To
Osteoprotegerin Deficiency (Juvenile Paget’s Disease): Responses to Oral and IV Bisphosphonates in 3 Children Deborah Wenkert1, Marc D. Natter2, Mayumi Otsuka3, Natalya E. Fish2, Jorge M. Lopez-Benitez2, Morri Markowitz4, William McAlister5, Steven Mumm5, Michael P. Whyte5 1Shriners Hospt Children, St Louis, MO, USA, 2Tufts-New Eng Med Ctr, Boston, MA, USA, 3N. Navajo Med Cntr, Shiprock, NM, USA, 4Montefiore Hospt, Bronx, NY, USA, 5Wash U Sch Med, St Louis, MO, USA. Abstract Patient 1 Patient 2 Patient 3 Discussion Osteoprotegerin (OPG) deficiency, the principal variant of juvenile Paget’s disease, is a rare, JPD, previously called idiopathic or hereditary hyperphosphatasia, presents in infancy, young childhood or, rarely, autosomal recessive osteopathy featuring markedly accelerated bone turnover. Here, we assess in late childhood. It causes deafness, bone pain, fracture, and deformity with x-rays showing undertubulation of responses of 3 affected, unrelated children to bisphosphonate (BP) therapy (Table). long bones with a disorganized trabecular pattern and thin cortices. Rapid rates of skeletal remodeling are demonstrated by histopathology as well as by biochemical markers of bone turnover, including especially Pt #1: A 4 yr old boy of Cypriot descent suffered leg swelling, periosteal elevation, and ESR=74 impressive hyperphosphatasemia. Most JPD patients are homozygous for a loss-of-function mutation in from "Caffey disease" diagnosed at age 1 mo. Alkaline phosphatase (ALP) reached 2470 U/l. TNFRSF11B encoding OPG, including missense defects, insertions/deletions, and frame shifts.(4,5,7,8,11) OPG acts Hearing (normal at birth) was lost by 21 mo. Three fxs and warm, bony expansions deformed all 3 11/12 yrs as a decoy receptor for RANK Ligand, thus suppressing bone turnover.
[Show full text]